Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Maintenance therapy in chronic obstructive pulmonary disease
Age: Adult
Dose: Inhalation – 62.5 mcg/25 mcg
Frequency: once daily
Indication: Maintenance therapy in chronic obstructive pulmonary disease
Age: Adult
Condition: Moderate hepatic impairment (Child-Pugh 7-9)
Dose: Inhalation – 62.5 mcg/25 mcg
Frequency: once daily
Note: No dosage adjustment is required

Child Dose

Clinical InformationAdministration Information
Age: Child
Dose: No approved pediatric dosage available
Note: Not recommended

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment (including severe [Creatinine Clearance <30 mL/minute])
Dose: Not specified
Note: No dosage adjustment is required
Administration
  • Take one inhalation daily
  • Use at same time each day
Side Effect

Drug Interaction

Drug NameRisk Factors
Other anticholinergic drugs
Additive effect with umeclidinium
Strong CYP3A4 inhibitors (e.g. ketoconazole, clarithromycin)
Increased exposure with vilanterol

Disease Interaction

Disease NameRisk Factors
No specific contraindications listed
Monitor for general drug reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.